ReposiTrak (TRAK) CEO Randall Fields discloses 10b5-1 stock sales and holdings
Rhea-AI Filing Summary
ReposiTrak, Inc. chairman and chief executive officer Randall K. Fields, who is also a director and 10% owner, reported a series of automatic sales of ReposiTrak common stock made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan.
The LLC sold 4,453 shares on 12/03/2025 at a weighted average price of $13.4023, 3,000 shares on 12/08/2025 at $13.7212, 2,500 shares on 12/09/2025 at $13.6363, and 2,000 shares on 12/10/2025 at $13.6991, all coded as open-market sales. The prices reflect multiple trades within disclosed price ranges on each day.
Following these transactions, RK Fields Charitable 2022, LLC held 182,500 shares of ReposiTrak common stock. Fields also reported additional holdings, including 3,483,955 shares of common stock held directly and various indirect positions through entities such as Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as related preferred stock holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $13.6991 | $27K |
| Sale | Common Stock | 2,500 | $13.6363 | $34K |
| Sale | Common Stock | 3,000 | $13.7212 | $41K |
| Sale | Common Stock | 4,453 | $13.4023 | $60K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
Footnotes (1)
- The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC. The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $12.905 to $13.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $13.52 to $13.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $13.5561 to $13.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $13.47 to $13.795, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
FAQ
What insider activity did ReposiTrak (TRAK) report in this Form 4?
The Form 4 reports that Randall K. Fields, ReposiTrak’s chairman, chief executive officer, director, and 10% owner, disclosed several open-market sales of ReposiTrak common stock executed through RK Fields Charitable 2022, LLC.
What is the purpose of the Rule 10b5-1 trading plan mentioned for TRAK?
The filing states that the trading plan was adopted by the reporting person in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust and established to enable him to meet some of his charitable commitments.
Are there any derivative securities reported for ReposiTrak (TRAK) in this Form 4?
Table II in the filing, which would list derivative securities such as options or warrants, does not report any derivative security transactions for this period.